Charafe-Jauffret Emmanuelle, Chaffanet Max, Bertucci François, Ginestier Christophe, Jacquemier Jocelyne, deLapeyrière Odile, Birnbaum Daniel
UMR 599 Inserm, Institut Paoli-Calmettes, Laboratoire d'Oncologie Moléculaire, Centre de Recherche en Cancérologie de Marseille et Université de la Méditerranée, 27, boulevard Leï Roure, 13009 Marseille, France.
Med Sci (Paris). 2007 Jun-Jul;23(6-7):626-32. doi: 10.1051/medsci/20072367626.
Breast cancer is a major health problem as well as scientifically poorly understood. Our knowledge of breast cancer is however rapidly progressing in several directions. First, genomic studies are establishing a new molecular classification of breast cancers. Molecular subtypes have been identified and are being associated with the histoclinical forms of breast cancers. Second, genetic alterations are discovered and classified, generating new potential therapeutical targets. Third, mammary stem cells have been identified in the normal mammary epithelium. Their altered counterparts have been identified in tumors and are being characterized. These combined studies allow a new integrated cellular and molecular definition of breast cancers and a conceptual basis that will help the management of the disease.
乳腺癌是一个重大的健康问题,并且在科学上还知之甚少。然而,我们对乳腺癌的认识正在多个方向迅速发展。首先,基因组研究正在建立一种新的乳腺癌分子分类。已经鉴定出分子亚型,并将其与乳腺癌的组织临床形式联系起来。其次,发现并分类了基因改变,产生了新的潜在治疗靶点。第三,在正常乳腺上皮中鉴定出了乳腺干细胞。在肿瘤中已经鉴定出它们发生改变的对应物,并正在对其进行特征描述。这些综合研究为乳腺癌提供了一个新的综合细胞和分子定义以及一个概念基础,这将有助于对该疾病的管理。